Vision-Sciences, Inc.  

(Public, NASDAQ:VSCI)   Watch this stock  
Find more results for VSCI
0.480
+0.018 (3.90%)
Mar 4 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.45 - 0.49
52 week 0.44 - 1.75
Open 0.47
Vol / Avg. 75,154.00/110,531.00
Mkt cap 23.29M
P/E     -
Div/yield     -
EPS -0.16
Shares 48.32M
Beta 0.70
Inst. own 4%
Feb 5, 2015
Q3 2015 Vision Sciences Inc Earnings Call - Webcast
Feb 4, 2015
Q3 2015 Vision Sciences Inc Earnings Release
Dec 22, 2014
Uroplasty Vision-Sciences Merger Announcement Conference Call
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -31.75% -45.09%
Operating margin -29.37% -43.51%
EBITD margin - -39.45%
Return on average assets -58.36% -69.46%
Return on average equity - -
Employees 105 -
CDP Score - -

Address

40 Ramland Rd S
ORANGEBURG, NY 10962-2623
United States - Map
+1-845-3650600 (Phone)
+1-845-3650620 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Vision-Sciences, Inc. designs, develops, manufactures, and markets products for endoscopy. The Company has two segments, Medical and Industrial. The Company�s medical segment designs, manufactures, and sells its advanced line of endoscopy-based products, including its flexible fiber and video endoscopes and its EndoSheath technology, for various specialties and markets. The Company�s industrial segment, through its wholly-owned subsidiary, Machida Incorporated (Machida), designs, manufactures, and sells borescopes to various users, primarily in the aircraft engine manufacturing and aircraft engine maintenance industries. The Company has developed two visualization platforms for flexible endoscopy: fiber optic (4000 Series) and video (5000 Series and 7000 Series). The Company targets five market spaces: Urology, Pulmonology, Surgery, Gastroenterology and ear, nose, and throat (ENT).

Officers and directors

Lewis C. Pell Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Howard I. Zauberman President, Chief Executive Officer, Director
Age: 61
Bio & Compensation  - Reuters
Gary Siegel Principal Financial Officer, Principal Accounting Officer, Vice President - Finance
Age: 56
Bio & Compensation  - Reuters
Mark S. Landman Vice President - Disposables Operations
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jitendra Patel Vice President - Industrial Division
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David W. Anderson Independent Director
Age: 61
Bio & Compensation  - Reuters
Katsumi Oneda Independent Director
Age: 76
Bio & Compensation  - Reuters
Cheryl Pegus M.D. Independent Director
Age: 49
Bio & Compensation  - Reuters
John J Rydzewski CPA Independent Director
Age: 61
Bio & Compensation  - Reuters